Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A2 | O95436 | 11/20 | 0.52 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.47 |
| ▸ | SLC34A3 | Q8N130 | 1/20 | 0.47 |
| ▸ | SLC20A1 | Q8WUM9 | 1/20 | 0.47 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | RAF1 | P04049 | 1/20 | 0.34 |
| ▸ | ADCYAP1R1 | P41586 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL269721 | 1.00 | SLC34A2 (0.52) | SLC34A2SLC34A1SLC34A3SLC20A1F10 | |
| SCHEMBL269720 | 1.00 | SLC34A2 (0.52) | SLC34A2SLC34A1SLC34A3SLC20A1F10 | |
| SCHEMBL267836 | 0.94 | SLC34A2 (0.47) | SLC34A2SLC34A1SLC34A3SLC20A1NOTUM | |
| SCHEMBL267029 | 0.94 | SLC34A2 (0.47) | SLC34A2SLC34A1SLC34A3SLC20A1NOTUM | |
| SCHEMBL274880 | 0.94 | SLC34A2 (0.47) | SLC34A2SLC34A1SLC34A3SLC20A1NOTUM | |
| SCHEMBL267028 | 0.94 | SLC34A2 (0.47) | SLC34A2SLC34A1SLC34A3SLC20A1NOTUM | |
| SCHEMBL267837 | 0.94 | SLC34A2 (0.47) | SLC34A2SLC34A1SLC34A3SLC20A1NOTUM | |
| SCHEMBL274085 | 0.94 | SLC34A2 (0.47) | SLC34A2SLC34A1SLC34A3SLC20A1NOTUM | |
| SCHEMBL266437 | 0.94 | SLC34A2 (0.49) | SLC34A2SLC34A1SLC34A3SLC20A1RAF1 | |
| SCHEMBL274508 | 0.94 | SLC34A2 (0.49) | SLC34A2SLC34A1SLC34A3SLC20A1RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120115851-A1 | COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20120115851-A1 | COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-8134015-B2 | Compound inhibiting in vivo phosphorous transport and medicine containing the same | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-8134015-B2 | Compound inhibiting in vivo phosphorous transport and medicine containing the same | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115851-A1 | COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME | SLC34A1, SLC34A2, SLC20A2 | SLC34A2 2/4885SLC34A1 1/4885SLC34A3 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.